Get the Stockscreener App
1.70
1.80%
+0.03
After Hours:
1.60
-0.10
-5.88%
Akari Therapeutics Plc ADR Stock (AKTX) Forecast
The Akari Therapeutics Plc ADR (AKTX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $4.3227, representing a +154.28% increase from the current price of $1.70. The highest analyst price target is $5.2164, and the lowest is $3.429.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AKTX Price Target
Average 3.9042
(+129.66% Upside)
Is Akari Therapeutics Plc ADR (AKTX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 62.91 | Neutral |
| STOCH(9,6) | 72.21 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.0806 | Buy |
| ADX(14) | 62.21 | Buy |
| William %R | -19.84 | Sell |
| CCI(14) | 273.68 | Buy |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.2981
Buy
|
1.3772
Buy
|
| MA20 |
1.2816
Buy
|
1.3926
Buy
|
| MA50 |
1.7425
Sell
|
1.7006
Sell
|
| MA100 |
2.2722
Sell
|
2.037
Sell
|
| MA200 |
2.486
Sell
|
1.951
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, AKTX could be considered a Moderate Sell, with 17 technical analysis indicators signaling 7 Buy signals, 8 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on AKTX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 62.91 indicates that AKTX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 72.21 indicates that AKTX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that AKTX is oversold. This suggests that AKTX price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 62.21 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 273.68 indicates that AKTX is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term AKTX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Akari Therapeutics Plc ADR financial reports and earnings history, Akari Therapeutics Plc ADR (AKTX) stock could reach $8.0477 by 2030, $7.7389 by 2040 and $12.34 by 2050. See the projected annual prices until 2050 of the Akari Therapeutics Plc ADR stock below:
- Akari Therapeutics Plc ADR (AKTX) is expected to reach an average price of $8.8219 in 2035, with a high prediction of $9.5782 and a low estimate of $8.4367. This indicates an $418.93% rise from the last recorded price of $1.70.
- Akari Therapeutics Plc ADR (AKTX) stock is projected to chart a bullish course in 2040, with an average price target of $7.6556, representing an $350.33% surge from its current level. The forecast ranges from a conservative $7.6216 to a sky-high $7.7389.
- Our analysts predict Akari Therapeutics Plc ADR (AKTX) to jump 517.24% by 2045, soaring from $10.37 to an average price of $10.49, potentially reaching $10.86. While $10.37 is the low estimate, the potential upside is significant.
- Akari Therapeutics Plc ADR (AKTX) stock is expected to climb by 2050, reaching an average of $12.26, a $620.94% jump from its current level. However, a wide range of estimates exists, with high and low targets of $12.34 and $12.16, respectively, highlighting the market's uncertainty.
Akari Therapeutics Plc ADR Stock (AKTX) Year by Year Forecast
Akari Therapeutics Plc ADR Stock (AKTX) Price Forecast for 2024
Our forecast for AKTX stock price in 2024 now indicates an average price target of $6.4565 with a high forecast of $9.9287 and a low forecast of $2.9842. The average prediction reflects an increase of +279.79% from the last recorded price of $1.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $3.4501 | $3.429 | $5.2164 | +102.95% |
| July, 2024 | $3.5491 | $3.2958 | $4.3216 | +108.77% |
| August, 2024 | $3.4761 | $3.3684 | $3.7874 | +104.47% |
| September, 2024 | $3.6577 | $3.2027 | $4.5093 | +115.16% |
| October, 2024 | $3.2645 | $3.2545 | $3.9919 | +92.03% |
| November, 2024 | $3.3213 | $3.2707 | $3.7671 | +95.37% |
| December, 2024 | $3.4823 | $3.3155 | $3.5997 | +104.84% |
Akari Therapeutics Plc ADR Stock (AKTX) Price Forecast for 2025
Akari Therapeutics Plc ADR Stock (AKTX) is expected to reach an average price of $3.5813 in 2025, with a high prediction of $4.5706 and a low estimate of $2.5919. This indicates an +110.66% rise from the last recorded price of $1.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.549 | $3.4364 | $4.2948 | +108.77% |
| February, 2025 | $3.4058 | $3.3574 | $3.6032 | +100.34% |
| March, 2025 | $3.5068 | $3.37 | $4.03 | +106.28% |
| April, 2025 | $3.5385 | $3.4793 | $3.7393 | +108.15% |
| May, 2025 | $3.1753 | $2.5919 | $3.5177 | +86.78% |
| June, 2025 | $3.6713 | $2.7345 | $3.7315 | +115.96% |
| July, 2025 | $3.7681 | $3.3597 | $4.3481 | +121.65% |
| August, 2025 | $3.8348 | $3.7249 | $4.5706 | +125.58% |
| September, 2025 | $3.8258 | $3.7258 | $4.4574 | +125.05% |
| October, 2025 | $3.7226 | $3.6426 | $3.9942 | +118.97% |
| November, 2025 | $3.4293 | $3.3893 | $3.7268 | +101.73% |
| December, 2025 | $3.5903 | $3.3885 | $3.677 | +111.19% |
Akari Therapeutics Plc ADR Stock (AKTX) Price Forecast for 2026
The predicted value for Akari Therapeutics Plc ADR (AKTX) in 2026 is set at an average of $4.734. Estimates vary from a peak of $6.1626 to a trough of $3.3055, indicating an +178.47% surge from the present price of $1.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.3771 | $3.3771 | $3.8588 | +98.65% |
| February, 2026 | $3.4639 | $3.3055 | $3.5855 | +103.76% |
| March, 2026 | $3.8148 | $3.4223 | $4.1164 | +124.40% |
| April, 2026 | $4.8716 | $3.6902 | $5.6916 | +186.56% |
| May, 2026 | $5.8284 | $4.3258 | $5.8484 | +242.85% |
| June, 2026 | $4.5293 | $4.3693 | $6.1626 | +166.43% |
| July, 2026 | $4.1861 | $4.0362 | $5.1861 | +146.24% |
| August, 2026 | $3.8471 | $3.7529 | $4.7345 | +126.30% |
| September, 2026 | $3.7939 | $3.7297 | $3.9097 | +123.17% |
| October, 2026 | $3.7106 | $3.6406 | $3.8379 | +118.27% |
| November, 2026 | $3.7316 | $3.6132 | $3.7848 | +119.51% |
| December, 2026 | $3.9284 | $3.6258 | $3.9584 | +131.08% |
Akari Therapeutics Plc ADR Stock (AKTX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Akari Therapeutics Plc ADR (AKTX) is $3.4945, with a high forecast of $3.9426 and a low forecast of $3.0464. This indicates an +105.56% increase from the last price of $1.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.7251 | $3.7151 | $3.9426 | +119.13% |
| February, 2027 | $3.8119 | $3.6082 | $3.9413 | +124.23% |
| March, 2027 | $3.8129 | $3.5129 | $3.8861 | +124.29% |
| April, 2027 | $3.6797 | $3.5997 | $3.8413 | +116.45% |
| May, 2027 | $3.6006 | $3.478 | $3.7937 | +111.80% |
| June, 2027 | $3.6474 | $3.4648 | $3.6574 | +114.55% |
| July, 2027 | $3.5542 | $3.4058 | $3.7216 | +109.07% |
| August, 2027 | $3.4051 | $3.2584 | $3.5784 | +100.30% |
| September, 2027 | $3.4319 | $3.3219 | $3.4577 | +101.88% |
| October, 2027 | $3.4487 | $3.2461 | $3.5087 | +102.86% |
| November, 2027 | $3.2696 | $3.2255 | $3.4713 | +92.33% |
| December, 2027 | $3.1372 | $3.0464 | $3.3622 | +84.54% |
Akari Therapeutics Plc ADR Stock (AKTX) Price Forecast for 2028
In 2028, Akari Therapeutics Plc ADR (AKTX) is projected to reach an average price of $3.2686, with a high projection of $3.9232 and a low estimate of $2.614. This indicates an +92.27% rise from the last price of $1.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.6674 | $3.1002 | $3.9232 | +115.73% |
| February, 2028 | $3.3742 | $3.3542 | $3.7116 | +98.48% |
| March, 2028 | $2.9209 | $2.8507 | $3.1691 | +71.82% |
| April, 2028 | $2.8335 | $2.7445 | $2.9651 | +66.68% |
| May, 2028 | $2.9413 | $2.8114 | $3.0076 | +73.02% |
| June, 2028 | $2.8555 | $2.8055 | $2.9971 | +67.97% |
| July, 2028 | $2.9264 | $2.7938 | $2.9679 | +72.14% |
| August, 2028 | $2.8533 | $2.8232 | $2.9558 | +67.84% |
| September, 2028 | $2.7501 | $2.74 | $2.8874 | +61.77% |
| October, 2028 | $2.681 | $2.614 | $2.7892 | +57.71% |
| November, 2028 | $2.6827 | $2.6351 | $2.7526 | +57.81% |
| December, 2028 | $2.6766 | $2.6582 | $2.7359 | +57.45% |
Akari Therapeutics Plc ADR Stock (AKTX) Price Forecast for 2029
The 2029 price forecast for Akari Therapeutics Plc ADR Stock (AKTX) is $7.0332 on average, with a high prediction of $11.41 and a low estimate of $2.6591. This represents an +313.72% increase from the previous price of $1.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.7143 | $2.6591 | $2.7283 | +59.67% |
| February, 2029 | $2.8018 | $2.7048 | $2.8022 | +64.81% |
| March, 2029 | $6.119 | $2.7448 | $6.559 | +259.94% |
| April, 2029 | $6.21 | $5.5816 | $6.4916 | +265.29% |
| May, 2029 | $6.0067 | $5.8383 | $6.9841 | +253.34% |
| June, 2029 | $6.0035 | $5.7235 | $6.6809 | +253.15% |
| July, 2029 | $5.7645 | $5.4861 | $6.1977 | +239.09% |
| August, 2029 | $4.4184 | $4.4084 | $5.8487 | +159.91% |
| September, 2029 | $4.7619 | $4.4468 | $4.9152 | +180.11% |
| October, 2029 | $4.7239 | $4.7239 | $4.9571 | +177.87% |
| November, 2029 | $6.9074 | $4.708 | $11.41 | +306.32% |
| December, 2029 | $6.1343 | $5.8926 | $8.3358 | +260.84% |
Akari Therapeutics Plc ADR Stock (AKTX) Price Forecast for 2030
Akari Therapeutics Plc ADR Stock (AKTX) is expected to reach an average price of $6.3016 in 2030, with a high forecast of $8.0477 and a low forecast of $4.5555. This signifies an +270.68% surge from the last price of $1.70.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.2212 | $6.0777 | $8.0477 | +265.95% |
| February, 2030 | $5.0065 | $4.9164 | $6.2813 | +194.50% |
| March, 2030 | $5.0991 | $4.8416 | $5.8632 | +199.95% |
| April, 2030 | $4.9605 | $4.9119 | $5.3458 | +191.80% |
| May, 2030 | $5.2455 | $4.7905 | $6.0887 | +208.56% |
| June, 2030 | $4.869 | $4.859 | $5.5839 | +186.41% |
| July, 2030 | $5.021 | $4.8794 | $5.3842 | +195.35% |
| August, 2030 | $5.1245 | $4.9993 | $5.2293 | +201.44% |
| September, 2030 | $5.1101 | $5.0664 | $5.9497 | +200.60% |
| October, 2030 | $5.56 | $5.0248 | $5.71 | +227.06% |
| November, 2030 | $5.2035 | $5.1435 | $5.5684 | +206.09% |
| December, 2030 | $4.6655 | $4.5555 | $5.4487 | +174.44% |
3.18%
Cap:
|
Volume (24h):